Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma

Yunfan Sun,Pin Wu,Zefan Zhang,Zejian Wang,Kaiqian Zhou,Minfang Song,Yuan Ji,Fenglin Zang,Limu Lou,Keqiang Rao,Pengxiang Wang,Yutong Gu,Jie Gu,Binbin Lu,Limeng Chen,Xiuqi Pan,Xiaojing Zhao,Lihua Peng,Dongbing Liu,Xiaofang Chen,Kui Wu,Penghui Lin,Liang Wu,Yulin Su,Min Du,Yingyong Hou,Xinrong Yang,Shuangjian Qiu,Yinghong Shi,Huichuan Sun,Jian Zhou,Xingxu Huang,David H Peng,Liye Zhang,Jia Fan,David H. Peng

DOI: https://doi.org/10.1016/j.ccell.2023.11.010

IF: 50.3

2024-01-09

Cancer Cell

Abstract:Sun et al. characterize multi-regional and multi-omics (genomics, transcriptomics, scRNA-seq, spatial transcriptomics, and IHC) profiles for paired primary and metastatic hepatocellular carcinoma from 182 patients. They reveal high intratumor heterogeneity in metastatic HCCs, complex evolutionary trajectories, subclonal selection, and crucial roles of tumor microenvironment (cancer-associated fibroblast and B cells) during metastasis.

oncology,cell biology

What problem does this paper attempt to address?

The problem this paper attempts to address is to reveal the spatiotemporal evolution of hepatocellular carcinoma (HCC) metastasis through integrative multi-omics analysis. Specifically, the researchers aim to solve this problem through the following explorations:

1. **Multi-regional and multi-omics characteristics**: By conducting multi-regional and multi-omics (genomics, transcriptomics, single-cell RNA sequencing, spatial transcriptomics, and immunohistochemistry) analyses on primary and metastatic HCC tumors from 182 patients, the study reveals the high heterogeneity, complex evolutionary trajectories, subclonal selection, and the critical role of the tumor microenvironment (such as cancer-associated fibroblasts and B cells) in metastasis.

2. **Genomic and transcriptomic characteristics**: The researchers detected single nucleotide variations and small insertions and deletions (Indels) in primary and metastatic tumors and identified frequently mutated genes to understand their roles in the metastatic process.

3. **Clonal origin tracing**: By reconstructing the phylogenetic trees of all sequenced tumors within patients, the researchers attempt to determine the clonal origins of metastatic tumors, particularly the relationships between multicentric primary tumors, recurrent tumors, and multiple metastatic tumors.

4. **Early metastatic dissemination**: The researchers explored the early emergence of metastatic precursors and the timing of late dissemination, modeling the temporal sequence of metastatic spread through the degree of genomic heterogeneity.

5. **Evolution of immune escape**: The researchers analyzed the heterogeneity within metastatic tumors, particularly the impact of neoantigen heterogeneity on tumor immunogenicity and anti-tumor immunity, and how the disruption of antigen processing and presentation mechanisms (APM) affects T cell function.

6. **Selective copy number variations**: The researchers identified highly selected copy number variations (SCNAs) during metastasis and assessed their roles in promoting metastasis.

In summary, this paper aims to reveal the complex biological mechanisms of HCC metastasis through comprehensive multi-omics analysis, providing new insights for treatment strategies for advanced HCC patients.